Antiva Biosciences

Antiva Biosciences

Antiva is a clinical stage biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by Human Papilloma Virus (HPV) infection. Antiva’s medicines were initially developed in the lab of Dr. Karl Hostetler at UC San Diego.

<< Portfolio